Self-management in patients with inflammatory bowel disease: Strategies, outcomes, and integration into clinical care

Clinical and Experimental Gastroenterology

Volumn 9, Issue , 2016, Pages 259-267

  Plevinsky, Jill M ^a   Greenley, Rachel N ^a   Fishman, Laurie N ^b  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Adherence; Communication; Crohn s disease; Self efficacy; Social support; Ulcerative colitis

Indexed keywords

CLINICAL PRACTICE; DOCTOR PATIENT RELATION; HEALTH CARE UTILIZATION; HUMAN; INFLAMMATORY BOWEL DISEASE; INTERPERSONAL COMMUNICATION; MOTIVATION; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PROBLEM SOLVING; REVIEW; SELF CARE; SELF CONCEPT; SOCIAL SUPPORT; TREATMENT PLANNING;

EID: 84983316673     PISSN: None     EISSN: 11787023     Source Type: Journal    
DOI: 10.2147/CEG.S106302     Document Type: Review

References (85)

1. Kappelman MD, Rigas-Shiman SL, Kleinman K, Ollendorf D, Bousvaros A, Grand RJ, Finkelstein JA. The prevalence and geographic distribution of Crohn’s disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007;5(12):1424–1429.
2. Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12(12):720–727.
3. Loftus E. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126(6):1504–1517.
4. Gasparetto M, Guariso G. Highlights in IBD epidemiology and its natural history in the paediatric age. Gastroenterol Res Pract. 2013;2013:829040.
5. Hommel KA, Greenley RN, Maddux MH, Gray WN, Mackner LM. Selfmanagement in pediatric inflammatory bowel disease: a clinical report of the North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2013;57(2):250–257.
6. Smolen DM, Topp R. Self-care agency and quality of life among adults diagnosed with inflammatory bowel disease. Qual Life Res. 2001;10(4):379–387.
7. Saibil F, Lai E, Hayward A, Yip J, Gilbert C. Self-management for people with inflammatory bowel disease. Can J Gastroenterol. 2008;22(3):281–287.
8. Robinson A. Review article: improving adherence to medication in patients with inflammatory bowel disease. Aliment Pharm Ther. 2008;27(Suppl 1):9–14.
9. Gallant MP. The influence of social support on chronic illness selfmanagement: a review and directions for research. Health Educ Behav. 2003;30(2):170–195.
10. Modi AC, Pai AL, Hommel KA, et al. Pediatric self-management: a framework for research, practice and policy. Pediatrics. 2012;129(2):e473–e485.
11. Barlow J, Wright C, Sheasby J, Turner A, Hainsworth J. Self-management approaches for people with chronic conditions: a review. Patient Educ Couns. 2002;48(2):177–187.
12. Barlow C, Cooke D, Mulligan K, Beck E, Newman S. A critical review of self-management and educational interventions in inflammatory bowel disease. Gastroenterol Nurs. 2010;33(1):11–18.
13. Flandt K. The chronic care model: description and application for practice. J Adv Pract Nurs. 2006;6(4):1–8.
14. Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA. 2002;288:2469–2475.
15. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA. 2002;288:1775–1779.
16. Litt IF, Cuskey WR. Satisfaction with health care: a predictor of adolescents’ appointment keeping. J Adolesc Health Care. 1984;5(3):196–200.
17. Hazzard A, Hutchinson SJ, Krawiecki N. Factors related to adherence to medication regiments in pediatric seizure patients. J Pediatr Psychol. 1990;15(4):543–555.
18. Hommel KA, Baldassano RN. Brief report: barriers to treatment adherence in pediatric inflammatory bowel disease. J Pediatr Psychol. 2010;35(9):683–691.
19. LeLeiko NS, Lobato D, Hagin S, et al. Rates and predictors of oral medication adherence with pediatric IBD. Inflamm Bowel Dis. 2013;19(4):832–839.
20. Mamula P, Markowitz J, Baldassano R. Inflammatory bowel disease in early childhood and adolescence: special considerations. Gastroenterol Clin North Am. 2003;32(3):967–995.
21. Tu W, Xu G, Du S. Structure and content components of self-management interventions that improve health-related quality of life in people with inflammatory bowel disease: a systematic review, meta-analysis and meta-regression. J Clin Nurs. 2015;24(19–20):2695–2709.
22. Huang J, Terrones L, Tompane T, et al. Preparing adolescents with chronic disease for transition to adult care: a technology program. Pediatrics. 2014;133(6):e1639–e1646.
23. Neinstien LS, Irwin CE. Young adults remain worse off than adolescents. J Adolescent Health. 2013;53(5):559–561.
24. Dashiff C, Vance D, Abdullatif H, Wallander J. Parenting, autonomy and self-care of adolescents with type 1 diabetes. Child Care Health Dev. 2008;35(1):79–88.
25. Bender BG. Risk taking, depression, adherence, and symptom control in adolescents and young adults with asthma. Am J Respir Crit Care Med. 2006;173:953–957.
26. Butow P, Palmer S, Pai A, Goodenough B, Luckett T, King M. Review of adherence-related issues in adolescents and young adults with cancer. J Clin Oncol. 2010;28(32):4800–4809.
27. Schwenk HT, Lightdale JR, Arnold JH, Goldmann DA, Weitzman ER. Coping with college and inflammatory bowel disease: implications for clinical guidance and support. Inflamm Bowel Dis. 2014;20(9):1618–1627.
28. Fishman L, Barendse RM, Hait E, Burdick C, Arnold J. Self-management of older adolescents with inflammatory bowel disease: a pilot study of behavior and knowledge as a prelude to transition. Clin Pediatr. 2010;49(12):1129–1133.
29. Robinson A, Thompson DG, Wilkin D, Roberts C; Northwest Gastrointestinal Research Group. Guided self-management and patientdirected follow-up of ulcerative colitis: a randomized trial. Lancet. 2001;358(9286):976–981.
30. Greenley RN, Nguyen E, Kunz JH, et al. Phone intervention to improve pediatric oral medication adherence: preliminary acceptability and feasibility. Inflamm Bowel Dis. 2011;17:S12–S57.
31. Greenley RN, Kunz JH, Walter J, Hommel KA. Practical strategies for enhancing adherence to treatment in inflammatory bowel disease. Inflamm Bowel Dis. 2013;19(7):1534–1545.
32. Bandura A. Self-efficacy: The Exercise of Control. New York, NY: W.H. Freeman and Company; 1997.
33. Nezu AM, Nezu CM, Perri MG. Problem solving to promote treatment adherence. In: O’Donohue WT, Levensky ER, editors. Promoting Treatment Adherence: A Practical Handbook for Health Care Providers. Thousand Oaks, CA: Sage Publications, Inc; 2006:135–148.
34. Keefer L, Kiebles, JL, Taft TH. The role of self-efficacy in inflammatory bowel disease management: preliminary validation of a disease-specific measure. Inflamm Bowel Dis. 2011;17(2):614–620.
35. Elliott TR, Grant JS, Miller DM. Social problem-solving abilities and behavioral health. In: Chang EC, D’Zurilla TJ, Sanna LJ, editors. Social Problem Solving: Theory, Research, and Practice. Washington, DC: American Psychological Association; 2006:117–134.
36. D’Zurilla TJ, Nezu AM, Maydeu-Olivares A. Social problem solving: theory and assessment. In: Chang EC, D’Zurilla TJ, Sanna LJ, editors. Social Problem Solving: Theory, Research, and Practice. Washington, DC: American Psychological Association; 2004:11–28.
37. Quittner AL, Drotar D, Ievers-Landis CE, Seidner D, Slockum N, Jackobsen J. Adherence to medical treatments in adolescents with cystic fibrosis: development and evaluation of family based interventions. In: Drotar D, editor. Promoting Adherence to Medical Treatment in Childhood Chronic Illness: Concepts, Methods, and Interventions. Mahwah, NJ: Erlbaum; 2000:383–408.
38. Wysocki T, Harris M, Greco P, et al. Randomized, controlled trial of behavior therapy for families of adolescents with insulin-dependent diabetes mellitus. J Pediatr Psychol. 2000;25(1):23–34.
39. Hill-Briggs F, Gemmell L. Problem solving in diabetes self-management and control: a systematic review of the literature. Diabetes Educ. 2007;33(6):1051–1052.
40. Modi AC, Guifoyle SM, Rausch J. Preliminary feasibility, acceptability, and efficacy of an innovative adherence intervention for children with newly diagnosed epilepsy. J Pediatr Psychol. 2013;38(6):605–616.
41. Wade SL, Stancin T, Kirkwood M, Brown TM, McMullen KM, Taylor HG. Counselor-assisted problem solving (CAPS) improves behavioral outcomes in older adolescents with complicated mild to severe TBI. J Head Trauma Rehab. 2014;29(3):198–207.
42. Cook PF, Emiliozzi S, El-Hajj E, McCabe MM. Telephone nurse counseling for medication adherence in ulcerative colitis: a preliminary study. Patient Educ Couns. 2010;81(2):182–186.
43. Solomon MR. Information technology to support self-management in chronic care: a systematic review. Dis Manag Health Out. 2008;16(6):391–401.
44. Haskard Zolnierek KB, DiMatteo MR. Provider communication skills and patient adherence to treatment: a meta-analysis. Med Care. 2009;47:826–834.
45. Zolnierek KBH, DiMatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Med Care. 2009;47(8): 826–834.
46. Sewitch MA, Abrahamowicz M, Barkun A, Bitton A, Wild GE, Cohen A, Dobkin PL. Patient nonaderence to medication in inflammatory bowel disease. Am J Gastroenterol. 2003;98(7):1535–1544.
47. Plevinsky JM, Gumidyala AP, Fishman LN. Transition experience of young adults with inflammatory bowel diseases (IBD): a mixed methods study. Child Care Health Dev. 2015;41(5):755–761.
48. Kerse N, Buetow S, Mainous AG, Young G, Coster G, Arroll B. Physician-patient relationship and medication compliance: a primary care investigation. Ann Fam Med. 2004;2(5):455–461.
49. Sleath BL, Carpenter DM, Slota C, et al. Communication during pediatric asthma visits and self-reported asthma medication adherence. Pediatrics. 2012;130(4):627–633.
50. Thatcher Shope J. Medication compliance. Pediatr Clin North Am. 1981;28:5–21.
51. Kennedy A, Nelson E, Reeves D, et al. Disease management and patient satisfaction in inflammatory bowel disease. Health Technol Asses. 2003;7(28):1–113.
52. Plener I, Hayward A, Saibil F. E-mail communication in the management of gastroenterology patients: a review. Can J Gastroenterol Hepatol. 2014;28(3):161–165.
53. DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol. 2004;23(2):207–218.
54. Moradkhani A, Beckman, LJ, Tabibian JH. Health-related quality of life in inflammatory bowel disease: psychosocial, clinical, socioeconomic, and demographic predictors. J Crohns Colitis. 2013;7(6):467–473.
55. van Groningen J, Ziniel S, Arnold J, Fishman LN. When independent health care behaviors develop in adolescents with inflammatory bowel disease. Inflamm Bowel Dis. 2012:18(12);2310–2314.
56. Reed-Knight B, Lewis JD, Blount RL. Association of disease, adolescent, and family factors with medication adherence in pediatric inflammatory bowel disease. J Pediatr Psychol. 2010;36(3):308–317.
57. Engstrom I, Lindquist BL. Inflammatory bowel disease in children and adolescents: a somatic and psychiatric investigation. Acta Paediatr Scand. 1991;80(6–7):640–647.
58. Nicholas DB, Otley A, Smith C, Avolio J, Munk M, Griffiths AM. Challenges and strategies of children and adolescents with inflammatory bowel disease: a qualitative examination. Health Qual Life Outcomes. 2007;5:28.
59. Janicke DM, Gray WN, Kahhan NA, Follansbee Junger KW, Marciel KK, Storch EA, Jolley CD. Brief report: the association between peer victimization, prosocial support, and treatment adherence in children and adolescents with inflammatory bowel disease. J Pediatr Psychol. 2008;34(7):769–773.
60. Saunders B. Stigma, deviance and morality in young adults’ accounts of inflammatory bowel disease. Sociol Health Illn. 2014;36(7):1020–1036.
61. Taft TH, Ballou S, Keefer L. A preliminary evaluation of internalized stigma and stigma resistance in inflammatory bowel disease. J Health Psychol. 2013;18(4):451–460.
62. Taft TH, Keefer L, Leonhard C, Nealon-Woods M. Impact of perceived stigma on inflammatory bowel disease patient outcomes. Inflamm Bowel Dis. 2009;15(8):1224–1232.
63. Strom JL, Egede LE. The impact of social support on outcomes in adult patients with type 2 diabetes: a systematic review. Curr Diab Rep. 2012;12(6):769–781.
64. Simoni JM, Frick PA, Huang B. A longitudinal evaluation of a social support model of medication adherence among HIV-positive men and women on antiretroviral therapy. Health Psychol. 2006;25(1):74–81.
65. Duncan TE, McAuley E. Social support and efficacy cognitions in exercise adherence: a latent growth curve analysis. J Behav Med. 1992;16(2):199–218.
66. Toljamo M, Hentinen M. Adherence to self-care and social support. J Clin Nurs. 2001;10(5):618–627.
67. Dudley-Brown S. Prevention of psychological distress in persons with inflammatory bowel disease. Issues Ment Health Nurs. 2002;23(4):403–422.
68. Plevinsky JM, Greenley RN. Exploring health-related quality of life and social functioning in adolescents with inflammatory bowel diseases after attending Camp Oasis and participating in a Facebook group. Inflamm Bowel Dis. 2014;20(9):1611–1617.
69. Shepanski MA, Hurd LB, Culton K, Markowitz JE, Mamula P, Baldassano RN. Health-related quality of life improves in children and adolescents with inflammatory bowel disease after attending a camp sponsored by the Crohn’s and Colitis Foundation of America. Inflamm Bowel Dis. 2005;11(2):164–170.
70. Salazar G, Heyman MB. Benefits of attending a summer camp for children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2014;59(1):33–38.
71. Hogan BE, Linden W, Najarian B. Social support interventions: do they work? Clin Psychol Rev. 2002;22(3):383–442.
72. Kahana S, Drotar D, Frazier T. Meta-analysis of psychological interventions to promote adherence to treatment in pediatric chronic health conditions. J Pediatr Psychol. 2008;33(6):590–611.
73. Izaguirre MR, Keefer L. Development of a self-efficacy scale for adolescents and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2014;59(1):29–32.
74. Zullig LL, Peterson ED, Bosworth HB. Ingredients of successful interventions to improve medication adherence. JAMA. 2013;310(24):2611–2612.
75. Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 1977;84(2):191–215.
76. Plante WA, Lobato D, Engel R. Review of group interventions for pediatric chronic conditions. J Pediatr Psychol. 2001;26(7):435–453.
77. Ingerski L, Baldassano RN, Denson LA, Hommel KA. Barriers to oral medication adherence for adolescents with inflammatory bowel disease. J Pediatr Psychol. 2010;35(6):683–691.
78. Kurylo MF, Elliott TR, Schewchuck RM. FOCUS on the family caregiver: a problem-solving training intervention. J Couns Dev. 2001;79(3):275–281.
79. D’Zurilla TJ, Nezu AM. Development and preliminary evaluation of the social problem solving inventory (SPSI). Psychol. Assess. 1990;2(2):156–163.
80. Donovan JL, Blake DR. Patient non-compliance: deviance or reasoned decision-making. Soc Sci Med. 1992;34(5):507–513.
81. Ivey JB, Wright A, Dashiff CJ. Finding the balance: adolescents with type 1 diabetes and their parents. J Pediatr Health Care. 2009;23(1):10–18.
82. Sarason IG, Sarason BR, Shearin EN. A brief measure of social support. J Soc Pers Relationships. 1987;4:497–510.
83. Dibb B, Yardley L. Factors important for the measurement of social comparison in chronic illness: a mixed-methods study. Chronic Illn. 2006;2(3):219–230.
84. Mackner L, Crandall W. Psychological factors affecting pediatric inflammatory bowel disease. Curr Opin Pediatr. 2007;19(5):548–552.
85. Wu YP, Pai ALH. Health care provider-delivered adherence promotion interventions: a meta-analysis. Pediatrics. 2014;133(6):1698–1707.